Literature DB >> 3391684

Enhanced chemiluminescence production by phagocytosing neutrophils in psoriasis.

F J Bloomfield1, M M Young.   

Abstract

Using serum-coated zymosan, the generation of reactive oxidants by measurement of chemiluminescence was shown to be significantly enhanced in isolated peripheral psoriatic neutrophils compared to normal controls. This response was observed irrespective of whether zymosan was opsonized with fresh autologous or normal AB serum. However, this increased activity was reduced with zymosan was opsonized with serum that was preheated at 56 degrees C for 30 min. There was no statistical correlation of chemiluminescence activity with degranulation of beta-glucuronidase in either normal or psoriatic subjects. In addition, chemiluminescence produced by normal cells was significantly increased when zymosan was opsonized with psoriatic serum. The plasma membrane-bound enzyme, NAD(P)H oxidase, which produces superoxide in response to phagocytic stimulation, was significantly increased in psoriatic neutrophils compared to normal controls. These data add further evidence for activated neutrophils in psoriasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391684     DOI: 10.1007/bf00916398

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  18 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

3.  Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis.

Authors:  F J Bloomfield; M M Young
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

4.  Neutrophil polymorphonuclears, mediators and the pathogenesis of psoriasis.

Authors:  M W Greaves
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

5.  Inflammatory and immune cell function in psoriasis--a subtle disorder I. In vivo and in vitro survey.

Authors:  G G Krueger; H R Hill; W W Jederberg
Journal:  J Invest Dermatol       Date:  1978-09       Impact factor: 8.551

6.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

7.  Characterisation of the enzyme defect in chronic granulomatous disease.

Authors:  A W Segal; T J Peters
Journal:  Lancet       Date:  1976-06-26       Impact factor: 79.321

8.  Influence of lithium and fluoride on degranulation from human neutrophils in vitro.

Authors:  F J Bloomfield; M M Young
Journal:  Inflammation       Date:  1982-09       Impact factor: 4.092

9.  Increased granulocyte adherence in psoriasis and psoriatic arthritis.

Authors:  J B Sedgwick; P R Bergstresser; E R Hurd
Journal:  J Invest Dermatol       Date:  1980-02       Impact factor: 8.551

10.  Increased respiratory burst activity of monocytes and polymorphonuclear leukocytes in psoriasis.

Authors:  R E Schopf; P Altmeyer; E M Lemmel
Journal:  Br J Dermatol       Date:  1982-11       Impact factor: 9.302

View more
  3 in total

1.  Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; R Hartung; H Kroeger
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

2.  Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

Review 3.  Neutrophils in Psoriasis.

Authors:  Chih-Chao Chiang; Wei-Jen Cheng; Michal Korinek; Cheng-Yu Lin; Tsong-Long Hwang
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.